Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs62282073 | chr3:141900767 | T/C | 1.75E-5 | 172 | 24.52 | 40.37 | 12.58 | KM Plot |
PCPG | rs62410847 | chr4:14923293 | C/G | 5.67E-5 | 171 | 28.3 | 18.2 | 10.73 | KM Plot |
PCPG | rs62431196 | chr6:130548232 | A/G | 0 | 177 | 26.27 | 15.88 | 3.17 | KM Plot |
PCPG | rs62481355 | chr7:127201664 | C/T | 0.00037 | 173 | 24.85 | 26.27 | 24.23 | KM Plot |
PCPG | rs630236 | chr8:104009041 | G/A | 2.65E-7 | 176 | 26.27 | 19.3 | 4.03 | KM Plot |
PCPG | rs631019 | chr8:104009172 | T/C | 2.65E-7 | 176 | 26.27 | 19.3 | 4.03 | KM Plot |
PCPG | rs632230 | chr13:37500963 | A/G | 4.9E-5 | 174 | 56.35 | 24.23 | 25.53 | KM Plot |
PCPG | rs638747 | chr3:80687528 | A/G | 0.000181 | 176 | 19.53 | 24.5 | 27.2 | KM Plot |
PCPG | rs6414219 | chr2:242544962 | A/T | 3.49E-5 | 175 | 25.87 | 29.57 | 20.2 | KM Plot |
PCPG | rs641490 | chr3:80693451 | A/G | 0.000294 | 178 | 27.4 | 24.02 | 19.53 | KM Plot |
PCPG | rs642681 | chr13:37511481 | G/A | 4.51E-5 | 176 | 56.35 | 24.17 | 25.7 | KM Plot |
PCPG | rs6429430 | chr1:243834477 | T/G | 0.000288 | 172 | 25 | 25.53 | 18.35 | KM Plot |
PCPG | rs642994 | chr8:104009578 | C/G | 2.65E-7 | 176 | 26.27 | 19.3 | 4.03 | KM Plot |
PCPG | rs6430588 | chr2:136554797 | T/C | 1.03E-6 | 172 | 9.72 | 24.65 | 25.6 | KM Plot |
PCPG | rs6436880 | chr2:230490249 | C/G | 1.16E-8 | 173 | 5.18 | 24.62 | 25.87 | KM Plot |